| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.3 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |